{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,7,8]],"date-time":"2026-07-08T04:58:53Z","timestamp":1783486733706,"version":"3.55.0"},"reference-count":8,"publisher":"Ovid Technologies (Wolters Kluwer Health)","issue":"6","content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":[],"published-print":{"date-parts":[[2017,6]]},"DOI":"10.1097\/rlu.0000000000001628","type":"journal-article","created":{"date-parts":[[2017,3,4]],"date-time":"2017-03-04T14:03:54Z","timestamp":1488636234000},"page":"454-455","source":"Crossref","is-referenced-by-count":11,"title":["Pituitary Adenoma Recurrence Suspected on Central Hyperthyroidism Despite Empty Sella and Confirmed by 68Ga-DOTA-TOC PET\/CT"],"prefix":"10.1097","volume":"42","author":[{"given":"Mathieu","family":"Gauth\u00e9","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Julie","family":"Sarfati","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Nathalie","family":"Bourcigaux","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Sophie","family":"Christin-Maitre","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jean-No\u00ebl","family":"Talbot","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Fran\u00e7oise","family":"Montravers","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"276","reference":[{"key":"R2-9-20210204","first-page":"540","article-title":"Somatostatin receptors on thyrotropin-secreting pituitary adenomas: comparison with the inhibitory effects of octreotide upon in vivo and in vitro hormonal secretions","volume":"75","author":"Bertherat","year":"1992","journal-title":"J Clin Endocrinol Metab"},{"key":"R3-9-20210204","doi-asserted-by":"crossref","first-page":"1224","DOI":"10.1007\/s00259-011-1760-x","article-title":"68Ga-DOTATOC PET\/CT and somatostatin receptor (sst1\u2013sst5) expression in normal human tissue: correlation of sst2 mRNA and SUVmax","volume":"38","author":"Boy","year":"2011","journal-title":"Eur J Nucl Med Mol Imaging"},{"key":"R4-9-20210204","doi-asserted-by":"crossref","first-page":"1617","DOI":"10.1007\/s00259-007-0450-1","article-title":"Comparison of 68Ga-DOTATOC PET and 111In-DTPAOC (Octreoscan) SPECT in patients with neuroendocrine tumours","volume":"34","author":"Buchmann","year":"2007","journal-title":"Eur J Nucl Med Mol Imaging"},{"key":"R5-9-20210204","doi-asserted-by":"crossref","first-page":"1115","DOI":"10.1007\/s00259-006-0110-x","article-title":"Comparison of the pharmacokinetics of 68Ga-DOTATOC and [18F]FDG in patients with metastatic neuroendocrine tumours scheduled for 90Y-DOTATOC therapy","volume":"33","author":"Koukouraki","year":"2006","journal-title":"Eur J Nucl Med Mol Imaging"},{"key":"R6-9-20210204","first-page":"68","article-title":"Comparison of (68)Ga-DOTA-Tyr(3)-octreotide and (18)F-fluoro-L-dihydroxyphenylalanine positron emission tomography in neuroendocrine tumor patients","volume":"54","author":"Putzer","year":"2010","journal-title":"Q J Nucl Med Mol Imaging"},{"key":"R7-9-20210204","doi-asserted-by":"crossref","first-page":"226","DOI":"10.1111\/iep.12024","article-title":"Somatostatin receptor expression in thyroid disease","volume":"94","author":"Atkinson","year":"2013","journal-title":"Int J Exp Pathol"},{"key":"R8-9-20210204","first-page":"728","article-title":"Indium-111 pentetreotide single-photon emission tomography in patients with TSH-secreting pituitary adenomas: correlation with the effect of a single administration of octreotide on serum TSH levels","volume":"24","author":"Losa","year":"1997","journal-title":"Eur J Nucl Med"},{"key":"R9-9-20210204","doi-asserted-by":"crossref","first-page":"e2358","DOI":"10.1097\/MD.0000000000002358","article-title":"Somatostatin analogue treatment of a TSH-secreting adenoma presenting with accelerated bone metabolism and a pericardial effusion: a case report","volume":"95","author":"Mousiolis","year":"2016","journal-title":"Medicine (Baltimore"}],"container-title":["Clinical Nuclear Medicine"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/journals.lww.com\/10.1097\/RLU.0000000000001628","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2021,5,14]],"date-time":"2021-05-14T06:18:33Z","timestamp":1620973113000},"score":1,"resource":{"primary":{"URL":"https:\/\/journals.lww.com\/00003072-201706000-00009"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2017,6]]},"references-count":8,"journal-issue":{"issue":"6","published-print":{"date-parts":[[2017]]}},"URL":"https:\/\/doi.org\/10.1097\/rlu.0000000000001628","relation":{},"ISSN":["0363-9762"],"issn-type":[{"value":"0363-9762","type":"print"}],"subject":[],"published":{"date-parts":[[2017,6]]}}}